Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for A7MCT6

Entry ID Method Resolution Chain Position Source
AF-A7MCT6-F1 Predicted AlphaFoldDB

23 variants for A7MCT6

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3390662306 43 P>S No EVA
rs3390575671 54 S>G No EVA
rs3388499155 65 G>A No EVA
rs3390654356 89 D>E No EVA
rs3388497572 127 V>I No EVA
rs3388499296 142 L>F No EVA
rs3390654363 166 R>Q No EVA
rs3388498047 177 E>K No EVA
rs3388497555 202 Y>F No EVA
rs3388498102 205 L>P No EVA
rs3388500748 227 E>D No EVA
rs3388500747 236 S>T No EVA
rs3390648081 239 D>G No EVA
rs3388501224 285 N>T No EVA
rs3390575687 292 V>E No EVA
rs3388499188 317 G>E No EVA
rs3388501483 325 V>M No EVA
rs3388497608 326 E>V No EVA
rs3388497828 334 K>E No EVA
rs3390575600 336 A>S No EVA
rs3388497352 355 T>I No EVA
rs3388499169 370 Q>* No EVA
rs3388499287 378 V>M No EVA

No associated diseases with A7MCT6

1 regional properties for A7MCT6

Type Name Position InterPro Accession
domain Damage-control phosphatase ARMT1-like, metal-binding domain 49 - 356 IPR002791

Functions

Description
EC Number 2.7.1.82 Phosphotransferases with an alcohol group as acceptor
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.

2 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
ethanolamine kinase activity Catalysis of the reaction: ATP + ethanolamine = ADP + 2 H(+) + phosphoethanolamine.

6 GO annotations of biological process

Name Definition
in utero embryonic development The process whose specific outcome is the progression of the embryo in the uterus over time, from formation of the zygote in the oviduct, to birth. An example of this process is found in Mus musculus.
multicellular organism growth The increase in size or mass of an entire multicellular organism, as opposed to cell growth.
phosphatidylethanolamine biosynthetic process The chemical reactions and pathways resulting in the formation of phosphatidylethanolamine, any of a class of glycerophospholipids in which a phosphatidyl group is esterified to the hydroxyl group of ethanolamine.
phosphorylation The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide.
placenta development The process whose specific outcome is the progression of the placenta over time, from its formation to the mature structure. The placenta is an organ of metabolic interchange between fetus and mother, partly of embryonic origin and partly of maternal origin.
post-embryonic development The process whose specific outcome is the progression of the organism over time, from the completion of embryonic development to the mature structure. See embryonic development.

9 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P20485 CKI1 Choline kinase Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) PR
P54352 eas Ethanolamine kinase Drosophila melanogaster (Fruit fly) PR
Q9HBU6 ETNK1 Ethanolamine kinase 1 Homo sapiens (Human) PR
P35790 CHKA Choline kinase alpha Homo sapiens (Human) PR
Q9D4V0 Etnk1 Ethanolamine kinase 1 Mus musculus (Mouse) PR
O54804 Chka Choline kinase alpha Mus musculus (Mouse) PR
Q01134 Chka Choline kinase alpha Rattus norvegicus (Rat) PR
D3ZRW8 Etnk2 Ethanolamine kinase 2 Rattus norvegicus (Rat) PR
Q8L518 At1g74320 Probable choline kinase 2 Arabidopsis thaliana (Mouse-ear cress) PR
10 20 30 40 50 60
MAVPPSAPVP CSPFYLRRQE PCPQCSWSME EKAVASAGCW EPPGPPRAAV PCFSVTVEQD
70 80 90 100 110 120
DILPGALRLI RELRPHWKPE QVRTKRFKDG ITNKLLACYV EEDMRDCVLV RVYGERTELL
130 140 150 160 170 180
VDRENEVRNF QLLRAHGCAP KLYCTFQNGL CYEYVQGVAL GPEHIREPQL FRLIALEMAK
190 200 210 220 230 240
IHTIHANGSL PKPTLWHKMH RYFTLVKDEI SPSLSADVPK VEVLEQELAW LKEHLSQLDS
250 260 270 280 290 300
PVVFCHNDLL CKNIIYDSDK GRVCFIDYEY AGYNYQAFDI GNHFNEFAGV NVVDYSRYPA
310 320 330 340 350 360
RETQVQWLRY YLEAQKGTAA SPREVERLYA QVNKFALASH FFWALWALIQ NQYSTISFDF
370 380
LRYAVIRFNQ YFKVKPQVSA LEMPK